Hemoglobin adducts of 10 polyfunctional amino-and nitro-substituted benzenes and toluenes were analyzed: 2,4,6-trinitrotoluene, 2,4-and 2,6-dinitrotoluene, 2-amino-4-nitrotoluene, 4-amino-2-nitrotoluene, 2,4-and 2,6-diaminotoluene, 1,3-dinitrobenzene, 1-amino-3-nitrobenzene, and 1,3-diaminobenzene. A 43-45 (1994) 
Introduction
Polyfunctional, monocyclic amino-and nitroarenes are widespread intermediates in chemical industries. They have recently attracted attention as soil contaminants in areas of former production and use of explosives (1) . Many of them were found mutagenic and carcinogenic in appropriate test systems, and may also be hazardous for humans if absorbed and metabolically activated (2) .
In vivo metabolism comprises reduction of nitro groups and oxidation of amino groups, resulting in N-nitroso intermediates that bind to the SH-group of cysteine in hemoglobin ( Figure 1 ) (3). The resulting sulfinamide can be hydrolyzed, which yields one or more cleavage products. These omonitor-2,4,6-trinitrotoluene from Promochem; t-6). As a and 2-amino-6-nitrotoluene, 2-amino-4-wmoglobin nitrotoluene, and 2-nitro-4-aminotoluene cperiments from Aldrich. For adduct analysis, 10 to 50 mg hemoglobin was hydrolyzed using structurally similar recovery standards in a solution of 0.3 ml 0.5% SDS, 3 ml aqua bidest, and 0.3 ml 10 N NaOH (alkaline hydrolysis) or 3 ml 10% H3PO4 (acidic hydrolysis). 
Results
After a single oral dose of the amino-and nitroarenes to female Wistar rats, all test compounds except one formed adducts that could be hydrolyzed from hemoglobin preparations under mild acidic or alkaline conditions. The exception was 2,4-diaminotoluene. The detection limit was in the range of 10 to 50 ng/g Hb for each cleavage product. Recovery of the substances was between 36 and 82%. None or extremely small amounts of the cleavage products were detected in control experiments in which hemoglobin was treated under neutral, but otherwise unchanged, conditions.
Animals treated with 1,3-dinitrobenzene developed visible met-hemoglobinemia (met-Hb) with the dose that was administered. One of them died after a few hours. These observations are in line with the known potency of this compound for metHb formation and its extent of hemoglobin binding. The HBIs of the two surviving animals were 98 and 40, respectively. However, the dose of 1,3-dinitrobenzene (0.5 mmole/kg) corresponded to the median lethal dose reported by Cody et al. (7) as 83 mg/kg (0.53 mmole/kg).
In general, toluene derivatives bind less extensively to hemoglobin than the correspondingly substituted benzenes. The total amount of hydrolyzable adducts varied Environmental Health Perspectives within a wide range; this is given in Table  1 as the HBI. Up to three cleavage products were detected, but one dominated in all cases. A specific pattern of hydrolyzable adducts was obtained for each chemical. The identified cleavage products and the percentage of the hydrolyzable and identified adducts are listed in Table 2 . The identification is based on HPLC cochromatography with authentic reference compounds under different conditions. Major cleavage products were also analyzed by GC-MS.
Discussion
Because metabolites that bind covalently to the SH-group of cysteine in hemoglobin are nitroso derivatives (3, 8) , our results demonstrate that such metabolites are formed either by in vivo reduction of a nitro group or by oxidation of an amino group. The chemical structure of the parent compounds apparently influences the metabolism in each case in a specific way, and thus determines the bioavailability of the reactive intermediate. With many of the compounds tested, N-acetylated adducts were formed. However, the ratio of acetylated to nonacetylated cleavage products was quite variable, which again indicates specific pharmacokinetics for each substance. No hydrolyzable adduct above the detection limit was obtained with 2,4-diaminotoluene. This is probably because of more extensive C-oxidation, including that of the methyl group.
The total amount and pattern of cleavage products permits the following conclusions: first, reduction of nitro groups exceeds N-oxidation of amino groups, as indicated by adduct formation. The low levels of hemoglobin binding by diaminosubstituted compounds may result from moderate amine oxidation or low bioavailability of the reactive metabolites. In addition, with nitroarenes nitroso-intermediates are likely to be formed by reduction of a nitro group rather than the reoxidation of an amino group after complete reduction. Second, addition of a methyl group lowers adduct formation, nitro substituents in para-position to the methyl group of toluene derivatives are preferably reduced. Third, alternate pathways such as C-oxidation, ring hydroxylation, and possibly quinone-imine generation also may be important metabolic pathways. Production of nonhydrolyzable adducts or more rapid elimination of detoxification products could be the reason for unexpected low hemoglobin-binding indices in some cases.
The compounds 2,4,6-trinitrotoluene, 2,4-and 2,6-dinitrotoluene, 2-amino-4-nitrotoluene, and 2,4-diaminotoluene are classified as carcinogenic in experimental animals. 1,3-Diaminobenzene and 1,3-dinitrobenzene are suspected of having carcinogenic potential (2) . This group of substances is therefore considered hazardous for exposed populations.
Soil in certain areas of former explosives production may contain rather large amounts of nitroarenes (1) . The actual uptake by different possible routes by people living or working or both in these areas is difficult to assess but should be measured as a basis for risk assessment. We propose to use the major hemoglobin adducts of 2,4,6-trinitrotoluene, 2,6-dinitrotoluene, and 1,3-dinitrobenzene as dosimeters for exposure in biomonitoring of potentially exposed populations.
Simple correlations between hemoglobin binding and carcinogenicity of this group of compounds could not be detected. More information is needed to understand better the complex pharmacokinetics of these chemicals and eventually to proceed from exposure control to risk assessment.
